A new, smaller tongue electrical impedance myography (EIM) array is reliable. The array preliminarily distinguishes between healthy and diseased muscle. Use of the array is well-tolerated.
h i g h l i g h t s
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a b s t r a c t
Objectives: Electrical impedance myography (EIM) measurements of the tongue could provide valuable information about bulbar dysfunction in amyotrophic lateral sclerosis (ALS). A prototype tongue depressor EIM array produced gag reflexes. The objectives of this study were to determine the reliability, mean phase values, and tolerability of tongue EIM measurements using a smaller electrode array. Methods: Tongue EIM measurements were performed in a total of 31 healthy individuals and four neuromuscular patients with lingual abnormalities. Reliability was assessed by calculating the intraclass correlation coefficient (ICC) and percent difference in addition to performing Bland-Altman analyses. Standard descriptive statistics, including results of a Mann-Whitney test, were also determined. Results: At the 50 kHz frequency, the ICCs for intra-and inter-rater reliability were 0.76 with 5.17% difference and 0.78 with 5.34% difference respectively. The mean EIM phase values of healthy participants (11.61°± 1.00°) and patients (9.87°± 1.28°) were significantly different (p = 0.0051). None of the participants experienced gag reflexes or discomfort. Conclusions: The small tongue array provided good inter-and intra-rater reliability, could preliminarily distinguish between healthy and diseased muscle, and was well-tolerated. Significance: Biomarker information about tongue health could be more comfortably obtained with a smaller EIM array. Ó 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
New biomarkers are essential to help hasten clinical therapeutic trials in amyotrophic lateral sclerosis (ALS) (Wagner, 2009) . To that end, imaging, biofluid, and neurophysiological metrics have been proposed as surrogates of disease state and response to treatment (Simon et al., 2014) . However, none of these measures are specific to the bulbar system. This is an important gap because bulbar dysfunction inevitably develops in the course of ALS, and approximately 25% of patients have predominantly bulbar symptoms at the time of disease onset (Haverkamp et al., 1995) . Craniobulbar muscle health can be assessed by standard needle electromyography (EMG), which often serves a critical role in the diagnosis of ALS (Makki and Benatar, 2007) . However, electrodiagnostic tests, including EMG, are sub-optimal tools for following disease progression and response to therapy due to associated discomfort (Gans and Kraft, 1977; Jan et al., 1999) . Further, orofacial muscle status is not easily quantified. Quantitative nerve conduction-based techniques used on limbs, such as motor unit number estimation, would be challenging to apply to genioglossus; it would be necessary to stimulate the hypoglossal nerve with needle electrodes and record motor unit potentials with surface electrodes placed on the tongue. As a painless, noninvasive approach that can be used to quantify tongue health, electrical impedance 
